Department of Internal Medicine, Ascension St. John Hospital, 19251 Mack Avenue, Suite 340, 48236, Detroit, MI, USA.
Department of Biomedical Investigations and Research, Ascension St. John Hospital, Detroit, MI, USA.
Virol J. 2024 Mar 21;21(1):71. doi: 10.1186/s12985-024-02325-x.
COVID-19 disease resulted in over six million deaths worldwide. Although vaccines against SARS-CoV-2 demonstrated efficacy, breakthrough infections became increasingly common. There is still a lack of data regarding the severity and outcomes of COVID-19 among vaccinated compared to unvaccinated individuals.
This was a historical cohort study of adult COVID-19 patients hospitalized in five Ascension hospitals in southeast Michigan. Electronic medical records were reviewed. Vaccine information was collected from the Michigan Care Improvement Registry. Data were analyzed using Student's t-test, analysis of variance, the chi-squared test, the Mann-Whitney and Kruskal-Wallis tests, and multivariable logistic regression.
Of 341 patients, the mean age was 57.9 ± 18.3 years, 54.8% (187/341) were female, and 48.7% (166/341) were black/African American. Most patients were unvaccinated, 65.7%, 8.5%, and 25.8% receiving one dose or at least two doses, respectively. Unvaccinated patients were younger than fully vaccinated (p = 0.001) and were more likely to be black/African American (p = 0.002). Fully vaccinated patients were 5.3 times less likely to have severe/critical disease (WHO classification) than unvaccinated patients (p < 0.001) after controlling for age, BMI, race, home steroid use, and serum albumin levels on admission. The case fatality rate in fully vaccinated patients was 3.4% compared to 17.9% in unvaccinated patients (p = 0.003). Unvaccinated patients also had higher rates of complications.
Patients who were unvaccinated or partially vaccinated had more in-hospital complications, severe disease, and death as compared to fully vaccinated patients. Factors associated with severe COVID-19 disease included advanced age, obesity, low serum albumin, and home steroid use.
COVID-19 疾病导致全球超过 600 万人死亡。尽管针对 SARS-CoV-2 的疫苗显示出了疗效,但突破性感染变得越来越普遍。与未接种疫苗的个体相比,关于接种疫苗的个体 COVID-19 的严重程度和结局的数据仍然缺乏。
这是一项在密歇根州东南部五家 Ascension 医院住院的成年 COVID-19 患者的历史队列研究。对电子病历进行了回顾。从密歇根州医疗改善注册处收集疫苗信息。使用学生 t 检验、方差分析、卡方检验、Mann-Whitney 和 Kruskal-Wallis 检验以及多变量逻辑回归分析数据。
在 341 名患者中,平均年龄为 57.9±18.3 岁,54.8%(187/341)为女性,48.7%(166/341)为黑人/非裔美国人。大多数患者未接种疫苗(65.7%),分别有 8.5%和 25.8%的患者接种了一剂或至少两剂疫苗。未接种疫苗的患者比完全接种疫苗的患者年轻(p=0.001),且更有可能为黑人/非裔美国人(p=0.002)。在控制年龄、BMI、种族、入院时家中使用类固醇和血清白蛋白水平后,完全接种疫苗的患者发生严重/危重症疾病(世界卫生组织分类)的可能性比未接种疫苗的患者低 5.3 倍(p<0.001)。完全接种疫苗的患者的病死率为 3.4%,而未接种疫苗的患者为 17.9%(p=0.003)。未接种疫苗的患者还存在更高的并发症发生率。
与完全接种疫苗的患者相比,未接种或部分接种疫苗的患者住院并发症、严重疾病和死亡的发生率更高。与严重 COVID-19 疾病相关的因素包括年龄较大、肥胖、低血清白蛋白和家中使用类固醇。